Medtronic plc (MDT) Shares are Up 1.34%

Medtronic plc (MDT) : Traders are bullish on Medtronic plc (MDT) as it has outperformed the S&P 500 by a wide margin of 0.86% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.81%, relative to the S&P 500. The stock has risen by 1.34% in the past week indicating that the buyers are active at lower levels, but the stock is down -1.18% in the past 4 weeks.

The stock has recorded a 20-day Moving Average of 0.53% and the 50-Day Moving Average is 1.42%.The 200 Day SMA reached 7.46% Medtronic plc is up 2.73% in the last 3-month period. Year-to-Date the stock performance stands at 12.94%.


Medtronic plc (MDT) : 14 investment research analysts covering Medtronic plc (MDT) have an average price target of $91.71 for the near short term. The highest target price given by the Brokerage Firm to the stock is $104 and the lowest target is $56 for the short term. Analysts expect the variance to be within $11.28 of the average price.

For the current week, the company shares have a recommendation consensus of Buy. Medtronic plc (NYSE:MDT): The stock opened at $85.76 and touched an intraday high of $86.085 on Friday. During the day, the stock corrected to an intraday low of $85.55, however, the bulls stepped in and pushed the price higher to close in the green at $86.01 with a gain of 0.41% for the day. The total traded volume for the day was 7,781,975. The stock had closed at $85.66 in the previous trading session.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *